Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp, trading under the ticker FLAC, is a blank-check company sponsored by Frazier Life Sciences, a life sciences-focused investment firm with a long track record in biopharma and healthcare. The SPAC completed its IPO in 2020, targeting acquisition opportunities in the life sciences and biotechnology sector. On January 31, 2022, the company filed a Form 10-Q/A — an amended quarterly report — with the SEC under accession number 0001193125-22-023438, reflecting updated disclosures for a prior reporting period. Sign up for full data on SpacDesk to access FLAC's complete filing history, deal timeline, and sponsor background.